Cargando…
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
Patients who develop osteosarcoma in 2017 receive treatment that remains essentially unchanged since the 1970s. Outcomes likewise remain largely unimproved. Large, collaborative, multinational efforts to improve therapy have evaluated strategies leveraging both cytotoxic intensification and immunomo...
Autores principales: | Saraf, Amanda J., Fenger, Joelle M., Roberts, Ryan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790793/ https://www.ncbi.nlm.nih.gov/pubmed/29435436 http://dx.doi.org/10.3389/fonc.2018.00004 |
Ejemplares similares
-
Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
por: Fan, Timothy M., et al.
Publicado: (2020) -
Characterizing the metabolic role of STAT3 in canine osteosarcoma
por: Gardner, Heather L., et al.
Publicado: (2022) -
Ferroptosis in osteosarcoma: A promising future
por: Liu, Xiang, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
por: Zhang, Zeng, et al.
Publicado: (2022) -
Peripheral T-Cell Lymphomas: A Review of Current Approaches and Hopes for the Future
por: Skarbnik, Alan P., et al.
Publicado: (2013)